Vecuronium
Back to searchMolecule Structure
Scientific Name
Vecuronium
Description of the Drug
Vecuronium is a nondepolarizing neuromuscular blocking agent used to relax muscles or as an adjunct in general anesthesia during surgical procedures.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-02-07 from
http://www.drugbank.ca/drugs/DB01339
http://www.drugbank.ca/drugs/DB01339
Brand Name(s)
Not Available
Company Owner(s)
Sagent Pharmaceuticals Inc, Watson Laboratories Inc, Teva Pharmaceuticals Usa, Hikma Farmaceutica Portugal Sa, West-Ward Pharmaceuticals International Ltd, Hospira Inc, Gland Pharma Ltd, Organon Usa Inc, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Muscle-type nicotinic acetylcholine receptor | PROTEIN COMPLEX GROUP | ANTAGONIST | CHEMBL2362997 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL13575838 | ||
| PharmGKB | PA164748865 | ||
| Human Metabolome Database | HMDB0015432 | ||
| DrugBank | DB01339 | ||
| PubChem: Thomson Pharma | 14837446 | ||
| PubChem | 39765 | ||
| Mcule | MCULE-4520566918 | ||
| LINCS | LSM-5367 | ||
| Nikkaji | J355.440F | ||
| EPA CompTox Dashboard | DTXSID1044146 | ||
| DrugCentral | 2811 | ||
| Guide to Pharmacology | 4002 | ||
| GSRS | b53aff89-25b6-4e19-8522-e6631965d288 | ||
| rxnorm | VECURONIUM BROMIDE | VECURONIUM CATION | VECURONIUM |
| KEGG Ligand | C07553 | ||
| ChEBI | 9939 | ||
| ZINC | ZINC000004097404 |
